How I treat patients with myelodysplastic syndromes.

Richard M Stone

Journal: Blood 2009;113(25):6296-303

PMID: 19383969

Free Full Text on Elsevier Science View on PubMed

Abstract

Address: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA. [email protected]

DOI: 10.1182/blood-2008-09-038935

Link outs

Free resources

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0006...

Medical:

https://medlineplus.gov/myelodysplasticsyndromes.h...

Subscription / membership required

Full Text Sources:

https://ashpublications.org/blood/article-lookup/d...

MeSH Terms: Acute Disease, Aged, Azacitidine, Chelation Therapy, Chromosome Deletion, Chromosomes, Human, Pair 5, Clinical Trials as Topic, DNA Methylation, Decitabine, Disease Progression, Erythropoietin, Hematopoietic Cell Growth Factors, Hematopoietic Stem Cell Transplantation, Humans, Iron Chelating Agents, Lenalidomide, Leukemia, Myeloid, Myelodysplastic Syndromes, Severity of Illness Index, Thalidomide, Transplantation, Homologous

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.